{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:10:42Z","timestamp":1788649842341,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41569-022-00721-w","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T10:03:42Z","timestamp":1653991422000},"page":"427-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Invention and uptake of TAVI over the first 20 years"],"prefix":"10.1038","volume":"19","author":[{"given":"Alain","family":"Cribier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"721_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0002-9149(84)90709-4","volume":"53","author":"Z Lababidi","year":"1984","unstructured":"Lababidi, Z., Wu, J. R. & Walls, J. T. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am. J. Cardiol. 53, 194\u2013197 (1984).","journal-title":"Am. J. Cardiol."},{"key":"721_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(86)90716-6","volume":"1","author":"A Cribier","year":"1986","unstructured":"Cribier, A. et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1, 63\u201367 (1986).","journal-title":"Lancet"},{"key":"721_CR3","first-page":"438","volume":"1","author":"H Eltchaninoff","year":"2006","unstructured":"Eltchaninoff, H. et al. Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency. EuroIntervention 1, 438\u2013444 (2006).","journal-title":"EuroIntervention"},{"key":"721_CR4","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.0000047200.36165.B8","volume":"106","author":"A Cribier","year":"2002","unstructured":"Cribier, A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006\u20133008 (2002).","journal-title":"Circulation"},{"key":"721_CR5","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jacc.2006.01.049","volume":"47","author":"A Cribier","year":"2006","unstructured":"Cribier, A. et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47, 1214\u20131223 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"721_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCULATIONAHA.105.582882","volume":"113","author":"JG Webb","year":"2006","unstructured":"Webb, J. G. et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842\u2013850 (2006).","journal-title":"Circulation"},{"key":"721_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ejcts.2008.01.046","volume":"33","author":"T Walther","year":"2008","unstructured":"Walther, T. et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur. J. Cardiothorac. Surg. 33, 983\u2013988 (2008).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"721_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jacc.2007.04.047","volume":"50","author":"E Grube","year":"2007","unstructured":"Grube, E. et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69\u201376 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"721_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian, A. et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561\u2013632 (2022).","journal-title":"Eur. Heart J."},{"key":"721_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jcin.2012.01.018","volume":"5","author":"E Durand","year":"2012","unstructured":"Durand, E. et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc. Interv. 5, 461\u2013467 (2012).","journal-title":"JACC Cardiovasc. Interv."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-022-00721-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-022-00721-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-022-00721-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:13:15Z","timestamp":1655471595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-022-00721-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1038\/s41569-022-00721-w","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"31 May 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C. is a consultant for Edwards Lifesciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}